The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE
George Frangeskides, Chairman at ALBA, explains why the Pilbara Lithium option ‘was too good to miss’
George Frangeskides, Chairman at ALBA, explains why the Pilbara Lithium option ‘was too good to miss’View Video
Charles Jillings, CEO of Utilico, energized by strong economic momentum across Latin America
Charles Jillings, CEO of Utilico, energized by strong economic momentum across Latin AmericaView Video

Latest Share Chat

Scrip Dividend Results

3 Sep 2018 17:00

RNS Number : 6262Z
Chenavari Toro Income Fund Limited
03 September 2018
 

Chenavari Toro Income Fund Limited (the Company)

3 September 2018

Results of 30 June 2018 Scrip Dividend

 

In connection with the scrip dividend offer made in respect of the dividend for the quarter ended 30 June 2018 of EUR 0.02 per ordinary share, the Company announces that it has received valid elections from Shareholders resulting in a requirement to transfer 30,838 Shares from treasury to relevant Shareholders.

Following the transfer, which is expected to settle on 14 September 2018, the remaining shares in issue total 361,450,000 (unchanged), of which 34,447,844 shares are held in treasury. Shares held in treasury carry no voting rights, therefore the total number of voting rights in the Company will be 327,002,156. This figure may be used by shareholders and other investors as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure Guidance and Transparency Rules.

 

Further information in relation to the Company is available at:

http://www.chenavaritoroincomefund.com

Enquiries:

Kirstie Sumarno

Chenavari Investment Managers

Email: tlir@chenavari.com

Telephone: +44 20 7259 3600

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
MSCSSWFIDFASEEU

Related Shares

Back to RNS

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.